Comorbidity in Patients with Rheumatoid Arthritis: What are the Real Concerns?
Stephen Paget, MD, FACP, FACR
Weill Cornell Medical College
|
Quantitatively-Driven Management of Rheumatoid Arthritis
Jonathan Kay, MD
University of Massachusetts Medical School
|
Applying Research to Your Practice: Focus on Nonbiologic DMARDs in 2009
Yusuf Yazici, MD
NYU Hospital for Joint Diseases
|
Rheumatoid Arthritis: The Heart of the Matter Assessing Cardiovascular Risk in Patients with Rheumatoid Arthritis
M. Elaine Husni, MD MPH
Cleveland Clinic, Cleveland Ohio
|
The Application of New ACR Recommendations in the Management of Rheumatoid Arthritis: A Case Study Approach
Kenneth G. Saag, MD, MSc
University of Alabama at Birmingham, Birmingham, Alabama
|
Safety of Novel Immunomodulatory Therapies
Arthur Kavanaugh, MD
University of California, San Diego
|
Failing a TNF Inhibitor: What About Switching?
Yusuf Yazici, MD
NYU Hospital for Joint Diseases
|
Prevention of Infection in Rheumatoid Arthritis Patients Receiving Biologic Agents
John J. Cush, MD
Baylor University Medical Center
|
Rheumatoid Arthritis and Imaging
Jonathan Kay, MD
Harvard Medical School
|
Treating a Patient with RA and Hepatitis B or C
Dimitrios Vassilopoulos, MD
Athens University School of Medicine
|
Therapeutic Issues in Rheumatoid Arthritis and Pregnancy
Nora G. Singer, MD
University Hospitals, Case Medical Center |
Rheumatoid Arthritis and Heart Failure
Marc D. Cohen, MD
National Jewish Medical and Research Center |
Managing Rheumatoid Arthritis Patients
with an Inadequate
Response to TNF Inhibitors
Sandeep K. Agarwal, MD, PhD
The University of Texas Health Science Center Houston–Medical School |
Rheumatoid Arthritis and Malignancy: Associations, Effects of Treatment, and Discussion of Options for Patients with Prior Cancer
Kevin M. Latinis, MD, PhD
University of Kansas Medical Center |
The Management of Difficult Rheumatoid Arthritis
Roy M. Fleischmann, MD
Metroplex Clinical Research Center |
